Pharmaceutical News and Articles

Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma

FDA Approves Gomekli (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

Most People Worldwide Lack Good Treatment for Mental Illness

About 93 of people worldwide who struggle with mental health or substance abuse issues aren t getting adequate care, a new report finds. In many cases, people a

'Playful' Approach to Life Pays Off, Study Finds

Want to thrive in tough, stressful times Stay playful. That s the take-home message from a new study of who fared best, in terms of mental resiliency, during th

Most Americans Keep Chronic Health Conditions Hidden at Work: Poll

Chronic ills like heart disease, asthma or diabetes afflict a majority of U.S. workers, but 60 of those affected say they ve kept their health issue a secret fr

Shark Attacks Plummeted Worldwide Last Year

It was a bit safer to go into the water last year Unprovoked shark attacks worldwide fell by about a third in 2024 compared to the year before, new data show. T

GLP-1 Meds Can Work Wonders for Kidney Health

Ozempic, Wegovy, Saxenda, Trulicity These and other GLP1-RA diabetes weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new res

Possible Listeria Contamination Prompts Recall of 2 Million Baked Goods

About 2 million baked goods have been recalled over concerns of potential contamination with Listeria monocytogenes, according to federal safety regulators.The

Effect of Behavioral Intervention on Reducing Care Overuse in Seniors Not Sustained

Clinical decision support (CDS) aimed at reducing overuse of care in seniors does not yield durable changes in terms of prostate-specific antigen (PSA) screenin

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis

Pliant Therapeutics, Inc. (Nasdaq PLRX) today announced that following a prespecified data review and recommendations by the trial s independent Data Safety Mon